Robert J. More, 10% Owner at Orexigen Therapeutics, Inc. (OREX), bought 4,201,948 shares at $12.00 ($6.3M) on 2007-05-01, disclosed to the SEC on 2007-05-01.
Open-market purchase of $6.3M OREX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 3,676,948 | $0 | 0.0% |
| 2 | $12.00 | 12,116 | $145K | 2.3% |
| 3 | $12.00 | 512,884 | $6.2M | 97.7% |
| Total | $1.50 avg | 4,201,948 | $6.3M | 100% |
| Filing → |
| TYRA | BUY | 2021-09-17 | $2.5M | — | Filing → |
| VIR | SELL | 2021-08-02 | $859K | — | Filing → |
| VIR | SELL | 2021-07-19 | $830K | — | Filing → |